References
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59:762–84.
Yokota S, Mori M, Imagawa T, Takei S, Murata T, Tomiita M, et al. Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists. Mod Rheumatol. 2007;17:353–63.
Samson CM, Waheed N, Baltatzis S, Foster CS. Methotrexate therapy for chronic noninfectious uveitis. Analysis of a case series of 160 patients. Ophthalmology. 2001;108:1134–9.
Malik AR, Pavesio C. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol. 2005;89:806–8.
Soheilian M, Aletaha M, Yazdani S, Dehghan MH, Peyman GA. Management of pediatric Vogt–Koyanagi–Harada (VKH)-associated panuveitis. Ocul Immunol Inflamm. 2006;14:91–8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kondo, Y., Fukuda, K., Suzuki, K. et al. Chronic noninfectious uveitis associated with Vogt–Koyanagi–Harada disease treated with low-dose weekly systemic methotrexate. Jpn J Ophthalmol 56, 104–106 (2012). https://doi.org/10.1007/s10384-011-0092-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-011-0092-5